We have located links that may give you full text access.
Gestational trophoblastic tumor at a tertiary level cancer center: a retrospective study.
Journal of Reproductive Medicine 2006 November
OBJECTIVE: To retrospectively analyze gestational trophoblastic disease at a tertiary level cancer center.
STUDY DESIGN: Thirty-six cases of gestational trophoblastic tumor at a tertiary level cancer hospital during the period 1996-2004 were studied. Various epidemiologic features were studied, diagnosed an and patients were classified according to the International Federation of Gynecology and Obstetrics scoring system. Chemotherapy was the main mode of treatment.
RESULTS: There was 100% success in low-risk cases and 90% success in high-risk cases.
CONCLUSION: Gestational trophoblastic tumors have an excellent prognosis if diagnosed and treated in time, and the potential for childbearing can be maintained.
STUDY DESIGN: Thirty-six cases of gestational trophoblastic tumor at a tertiary level cancer hospital during the period 1996-2004 were studied. Various epidemiologic features were studied, diagnosed an and patients were classified according to the International Federation of Gynecology and Obstetrics scoring system. Chemotherapy was the main mode of treatment.
RESULTS: There was 100% success in low-risk cases and 90% success in high-risk cases.
CONCLUSION: Gestational trophoblastic tumors have an excellent prognosis if diagnosed and treated in time, and the potential for childbearing can be maintained.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app